Why is Aristo Bio-Tech falling/rising?

As of 28-Oct, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 125.05, which reflects a decrease of 4.95 or 3.81%. The stock has underperformed its sector by 4.71% today, and its delivery volume has significantly dropped by 54.55% compared to the 5-day average, indicating falling investor participation. Additionally, while the stock is above its 200-day moving average, it is below the 5-day, 20-day, 50-day, and 100-day moving averages. Over the past week, the stock has decreased by 7.37%, and it has also shown negative returns over the past month and year, with declines of 9.25% and 7.81%, respectively.
In the broader market context, the Sensex has shown a positive return of 0.26% over the past week and 5.20% over the past month, contrasting sharply with Aristo Bio-Tech's negative performance. The stock's year-to-date return is also negative at -5.98%, while the Sensex has gained 9.69% during the same period. This stark difference highlights the underperformance of Aristo Bio-Tech relative to the broader market, suggesting that investor sentiment may be unfavorable towards the company compared to the overall market trends.